ALOX15 and cancer: While 15‐LOX expression is often reduced in various cancers such as colon, prostate, and breast cancer, its genetic or pharmacological activation has been shown to inhibit tumor growth by suppressing EGFR receptor activation, promoting apoptosis and inhibiting angiogenesis [97].